FDA Approved: PLERIXAFOR — Supplemental Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for Plerixafor filed by Novadoz Pharmaceuticals LLC, related to changes to labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

SUPPL AP for PLERIXAFOR (PLERIXAFOR)